About me
Jeremy Jokinen is the Vice President and Head of Global Patient Safety at argenx. He has more than 25 years of experience in the pharmaceutical industry, having held roles at Abbott Laboratories, Johnson & Johnson, AbbVie, and Bristol Myers Squibb. Jeremy has led numerous cross-industry pharmacovigilance workgroups and initiatives through organizations such as DIA, TransCelerate, and ICH, and is a frequent speaker at industry conferences. He began his career as a statistician and considers himself fortunate to have discovered the field of patient safety. He holds MS and PhD degrees in quantitative psychology from Ohio University.
